Acadia Healthcare (NASDAQ:ACHC) Upgraded by Zacks Research to Hold Rating

Acadia Healthcare (NASDAQ:ACHC) was upgraded by research analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research report issued to clients and investors on Thursday,Zacks.com reports.

Several other analysts have also recently commented on the stock. Royal Bank Of Canada upped their target price on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, February 26th. Raymond James Financial restated an “outperform” rating and set a $25.00 price objective on shares of Acadia Healthcare in a report on Thursday, February 26th. Cantor Fitzgerald set a $17.00 target price on shares of Acadia Healthcare in a report on Wednesday, December 3rd. Guggenheim lowered their price objective on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. Finally, KeyCorp reduced their target price on Acadia Healthcare from $30.00 to $25.00 and set an “overweight” rating on the stock in a report on Wednesday, December 3rd. Seven equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $21.15.

Acadia Healthcare Stock Up 3.9%

Shares of ACHC stock opened at $25.62 on Thursday. The stock’s 50 day simple moving average is $15.80 and its 200 day simple moving average is $18.69. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.44 and a current ratio of 1.55. Acadia Healthcare has a twelve month low of $11.43 and a twelve month high of $31.43. The company has a market capitalization of $2.36 billion, a price-to-earnings ratio of -2.10, a PEG ratio of 8.33 and a beta of 0.74.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The firm had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. During the same quarter in the prior year, the company earned $0.64 EPS. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, research analysts predict that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Investors Weigh In On Acadia Healthcare

Institutional investors have recently bought and sold shares of the company. Wellington Management Group LLP raised its holdings in shares of Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock valued at $167,077,000 after purchasing an additional 2,350,760 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Acadia Healthcare by 7.8% during the third quarter. Vanguard Group Inc. now owns 9,417,045 shares of the company’s stock worth $233,166,000 after purchasing an additional 681,278 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Acadia Healthcare by 417.8% during the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the last quarter. Abrams Bison Investments LLC grew its position in Acadia Healthcare by 22.3% in the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after purchasing an additional 800,000 shares in the last quarter. Finally, UBS Group AG increased its stake in Acadia Healthcare by 8.8% in the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after buying an additional 350,484 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.